Korro Bio, Inc.
KRRO
$6.04
$0.7614.39%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -25.34% | -42.75% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -25.34% | -42.75% | |||
| Cost of Revenue | -42.37% | -- | |||
| Gross Profit | 43.85% | -762.67% | |||
| SG&A Expenses | -12.04% | -3.32% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -29.08% | 3.96% | |||
| Operating Income | 29.28% | -8.72% | |||
| Income Before Tax | 29.91% | -10.19% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 29.91% | -10.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 29.91% | -10.19% | |||
| EBIT | 29.28% | -8.72% | |||
| EBITDA | 30.48% | -9.16% | |||
| EPS Basic | 29.92% | -10.12% | |||
| Normalized Basic EPS | 29.92% | -10.11% | |||
| EPS Diluted | 29.92% | -10.12% | |||
| Normalized Diluted EPS | 29.92% | -10.11% | |||
| Average Basic Shares Outstanding | 0.01% | 0.07% | |||
| Average Diluted Shares Outstanding | 0.01% | 0.07% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||